Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease.
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease. — المؤلف: Holdstock, Louis — Clinical kidney journal Feb 2019
- المؤلف
- Holdstock, Louis
- النشر
- Clinical kidney journal Feb 2019
- الوصف
- 129-138 p.